- Home
- CTMX vs GRNT Comparison
CTMX vs GRNT Comparison
Compare CTMX & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- GRNT
- Stock Information
- Founded
- CTMX 2008
- GRNT 2013
- Country
- CTMX United States
- GRNT United States
- Employees
- CTMX N/A
- GRNT N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- GRNT Blank Checks
- Sector
- CTMX Health Care
- GRNT Finance
- Exchange
- CTMX Nasdaq
- GRNT Nasdaq
- Market Cap
- CTMX 596.2M
- GRNT 675.9M
- IPO Year
- CTMX 2015
- GRNT N/A
- Fundamental
- Price
- CTMX $3.39
- GRNT $5.20
- Analyst Decision
- CTMX Strong Buy
- GRNT Buy
- Analyst Count
- CTMX 5
- GRNT 1
- Target Price
- CTMX $5.80
- GRNT $8.00
- AVG Volume (30 Days)
- CTMX 3.0M
- GRNT 399.5K
- Earning Date
- CTMX 11-07-2025
- GRNT 11-06-2025
- Dividend Yield
- CTMX N/A
- GRNT 8.51%
- EPS Growth
- CTMX 263.20
- GRNT N/A
- EPS
- CTMX 0.49
- GRNT 0.25
- Revenue
- CTMX $141,100,000.00
- GRNT $409,332,000.00
- Revenue This Year
- CTMX N/A
- GRNT $35.82
- Revenue Next Year
- CTMX N/A
- GRNT $10.41
- P/E Ratio
- CTMX $6.79
- GRNT $21.02
- Revenue Growth
- CTMX 18.01
- GRNT 10.32
- 52 Week Low
- CTMX $0.40
- GRNT $4.52
- 52 Week High
- CTMX $3.91
- GRNT $7.00
- Technical
- Relative Strength Index (RSI)
- CTMX 57.06
- GRNT 44.04
- Support Level
- CTMX $3.21
- GRNT $5.16
- Resistance Level
- CTMX $3.50
- GRNT $5.43
- Average True Range (ATR)
- CTMX 0.25
- GRNT 0.13
- MACD
- CTMX -0.06
- GRNT -0.01
- Stochastic Oscillator
- CTMX 35.42
- GRNT 20.81
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.